Industry
152d agoEli Lilly Buys AI Drug Tech for $2.75B
The $2.75 billion partnership between Eli Lilly and Insilico Medicine signals a major shift toward AI‑driven drug discovery.
The Signal
By integrating machine‑learning models into early‑stage research, the deal accelerates the development of novel therapies worldwide, reduces costs, and could reshape the pharmaceutical supply chain, setting a new industry benchmark and fostering global collaboration effort.